-
IPF patients taking antifibrotic therapies Ofev or Esbriet had a 37% lower mortality risk than those not treated, a registry-based study says.
IPF patients taking antifibrotic therapies Ofev or Esbriet had a 37% lower mortality risk than those not treated, a registry-based study says. Read more here.
What do you think of these findings?
-
2 Replies
-
Die we will. It will just take longer!
Piet.
-
Piet, no one gets out of this alive; we all get our ticket. Some are just to better places as a destination. So….I work to just live life now to the best I can for myself. I’m never bored and as things get worse, as they assuredly will, I will find more and different things that fill my mind and soul. Just sayin’.
Rand O’Brien
Log in to reply.